In this episode, Ajay Goel, PhD, AGAF, Professor and Chair, Department of Molecular Diagnostics and Experimental Therapeutics, City of Hope, discusses a promising blood-based test that detected 81% of advanced precancerous colorectal lesions and explores how earlier detection could shift cancer care toward prevention. He also examines screening access, reimbursement, follow-up care and the growing role of liquid biopsies in the future of oncology.
Dr. Ajay Goel on Blood-Based Screening and the Next Frontier of Cancer Prevention
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Chirag Choudhary, MD, MBA, Vice President and Chief Medical Officer for Cleveland Clinic Martin Health, and Marc…
-
In this episode, Robert Rose, DNP, System Chief Nursing Officer and Senior Vice President of Nursing at Ascension, joins the…
-
In this episode, Fiona Fang, CEO of Aetna Better Health of Florida, discusses Medicaid challenges, maternal and infant health, whole…
Comments are closed.